Home / Stocks / LQDA

Liquidia (LQDA, Drugmakers) Stock Valuation & Fair Value

No P/E valuation

Liquidia (LQDA, Drugmakers) trades at a current P/E of 33.7, trading without a historical P/E to compare against, with a forward growth estimate of 40.9% and a PEG of 0.83. Analysts' one-year estimates have been hit 14% of the time.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

This company has no P/E to compare against its own history, so tickerseer publishes no valuation rating for it. The figures below are unaffected.

DATA AS OF 2026-11-07
Current P/E
33.7
Normal P/E
—
PEG
0.83
Fwd growth
40.9%
Div yield
0.0%
RSI (14)
50.4
Neutral
Technical context
  • Price $44.40 at the Nov 6 close, 11.8% above the 20-day average ($39.73) and 11.9% below the 50-day ($50.38).
  • RSI (14) at 50.4.
  • 52-week range $25.91 to $91.03: the price is 51.2% below the high and 71.4% above the low.

The Street vs SeerForecast

Wall Street's mean price target for LQDA is $54.38 across 8 analysts, 22.5% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: we publish none, because it has no P/E to compare against its own history. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer has published no valuation rating since 2026-07-31, because this company has no P/E to compare against its own history.

Current P/E and rating by weekCurrent P/E moved from 51.7 to 34.2 between 2026-07-31 and 2026-10-30, with 0 rating changes over 14 recorded weeks.2026-07-31: P/E 51.7, No P/E valuation, recalculated for the week of 2026-07-312026-07-31: P/E 49.7, No P/E valuation, recorded live 2026-08-032026-08-07: P/E 49.7, No P/E valuation, recalculated for the week of 2026-08-072026-08-07: P/E 50.9, No P/E valuation, recorded live 2026-08-102026-08-14: P/E 50.9, No P/E valuation, recalculated for the week of 2026-08-142026-08-14: P/E 44.0, No P/E valuation, recorded live 2026-08-172026-08-21: P/E 44.0, No P/E valuation, recalculated for the week of 2026-08-212026-08-21: P/E 38.8, No P/E valuation, recorded live 2026-08-242026-08-27: P/E 38.8, No P/E valuation, recalculated for the week of 2026-08-272026-08-28: P/E 38.8, No P/E valuation, recalculated for the week of 2026-08-282026-08-28: P/E 38.8, No P/E valuation, recalculated for the week of 2026-08-302026-08-28: P/E 36.6, No P/E valuation, recorded live 2026-08-312026-09-04: P/E 36.6, No P/E valuation, recalculated for the week of 2026-09-052026-09-04: P/E 35.7, No P/E valuation, recorded live 2026-09-072026-09-11: P/E 35.7, No P/E valuation, recalculated for the week of 2026-09-122026-09-11: P/E 33.3, No P/E valuation, recorded live 2026-09-142026-09-18: P/E 33.3, No P/E valuation, recalculated for the week of 2026-09-192026-09-18: P/E 32.2, No P/E valuation, recorded live 2026-09-212026-09-25: P/E 32.2, No P/E valuation, recalculated for the week of 2026-09-262026-09-25: P/E 31.7, No P/E valuation, recorded live 2026-09-282026-10-02: P/E 31.7, No P/E valuation, recalculated for the week of 2026-10-032026-10-02: P/E 16.3, No P/E valuation, recorded live 2026-10-052026-10-09: P/E 16.3, No P/E valuation, recalculated for the week of 2026-10-102026-10-09: P/E 15.1, No P/E valuation, recorded live 2026-10-122026-10-16: P/E 15.1, No P/E valuation, recalculated for the week of 2026-10-172026-10-16: P/E 27.8, No P/E valuation, recorded live 2026-10-192026-10-23: P/E 33.2, No P/E valuation, recorded live 2026-10-262026-10-30: P/E 33.2, No P/E valuation, recalculated for the week of 2026-10-312026-10-30: P/E 34.2, No P/E valuation, recorded live 2026-11-0220.030.040.050.0Jul 31Aug 23Sep 15Oct 7Oct 30
No P/E valuationNo P/E valuation

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 51.7not availableNo P/E valuation (recalculated)
2026-10-12P/E 15.1not availableNo P/E valuation
2026-11-02P/E 34.2not availableNo P/E valuation ← now
Show all 29 readings
WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 51.7not availableNo P/E valuation (recalculated)
2026-08-03P/E 49.7not availableNo P/E valuation
2026-08-07P/E 49.7not availableNo P/E valuation (recalculated)
2026-08-10P/E 50.9not availableNo P/E valuation
2026-08-14P/E 50.9not availableNo P/E valuation (recalculated)
2026-08-17P/E 44.0not availableNo P/E valuation
2026-08-21P/E 44.0not availableNo P/E valuation (recalculated)
2026-08-24P/E 38.8not availableNo P/E valuation
2026-08-27P/E 38.8not availableNo P/E valuation (recalculated)
2026-08-28P/E 38.8not availableNo P/E valuation (recalculated)
2026-08-30P/E 38.8not availableNo P/E valuation (recalculated)
2026-08-31P/E 36.6not availableNo P/E valuation
2026-09-05P/E 36.6not availableNo P/E valuation (recalculated)
2026-09-07P/E 35.7not availableNo P/E valuation
2026-09-12P/E 35.7not availableNo P/E valuation (recalculated)
2026-09-14P/E 33.3not availableNo P/E valuation
2026-09-19P/E 33.3not availableNo P/E valuation (recalculated)
2026-09-21P/E 32.2not availableNo P/E valuation
2026-09-26P/E 32.2not availableNo P/E valuation (recalculated)
2026-09-28P/E 31.7not availableNo P/E valuation
2026-10-03P/E 31.7not availableNo P/E valuation (recalculated)
2026-10-05P/E 16.3not availableNo P/E valuation
2026-10-10P/E 16.3not availableNo P/E valuation (recalculated)
2026-10-12P/E 15.1not availableNo P/E valuation
2026-10-17P/E 15.1not availableNo P/E valuation (recalculated)
2026-10-19P/E 27.8not availableNo P/E valuation
2026-10-26P/E 33.2not availableNo P/E valuation
2026-10-31P/E 33.2not availableNo P/E valuation (recalculated)
2026-11-02P/E 34.2not availableNo P/E valuation ← now

Frequently asked questions

Is Liquidia stock overvalued?

At a current P/E of 33.7, Liquidia has no historical normal P/E on record to compare that against, with a PEG of 0.83 on 40.9% forward growth. tickerseer therefore publishes no valuation rating for it.

What is Liquidia's fair value and PEG?

Liquidia trades at a current P/E of 33.7, a PEG of 0.83, and a forward growth estimate of 40.9%.

Has tickerseer's rating of Liquidia changed?

tickerseer has published no valuation rating since 2026-07-31, because this company has no P/E to compare against its own history.

What is the analyst price target for Liquidia?

The mean Wall Street price target for Liquidia is $54.38 across 8 analysts, 22.5% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Drugmakers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track LQDA free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.